JEF

Business Context and Reporting Period

This summary covers the Form 10-Q filed by Leucadia National Corporation for the quarterly period ended September 30, 2007. The registrant is a large accelerated filer. The company operates as a diversified holding company with segments including manufacturing (Idaho Timber, Conwed Plastics), telecommunications (STi Prepaid), property management (ResortQuest), gaming entertainment (Premier), domestic real estate, and medical product development (Sangart). Significant corporate activity during the period included the acquisition of STi Prepaid and ResortQuest, the reconsolidation of Premier Entertainment Biloxi, LLC following its emergence from bankruptcy, and substantial equity investments in associated companies such as Jefferies High Yield Holdings, LLC and Pershing Square.

Key Financial Metrics

Liquidity: As of September 30, 2007, the company held $695.1 million in cash and cash equivalents. Total investments (current and non-current) aggregated $3.02 billion. Management estimates approximately $3.15 billion of liquid assets are available to meet liquidity needs, excluding pledged collateral and restricted funds.

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenues increased 94.5% for the three months and 27.1% for the nine months compared to the prior year periods. This growth is primarily driven by the inclusion of new segments: Telecommunications (STi Prepaid) and Property Management (ResortQuest), which were acquired in 2007.
• Net Income Decline: Despite revenue growth, net income for the nine months ended September 30, 2007, dropped significantly to $38.6 million from $178.2 million in the prior year. The 2006 period included substantial one-time gains from the disposal of discontinued operations (Symphony Healthcare and ATX Communications) totaling approximately $59.4 million pre-tax, which were not present in 2007.
• Operating Cash Flow: Operating cash flow turned negative ($5.1 million used) for the nine months of 2007 compared to $68.6 million provided in 2006. This shift reflects decreased collections of receivables, increased income tax payments, and the absence of the $179.8 million collection from AT&T in 2006 related to the WilTel termination agreement.
• Debt Levels: Total debt increased significantly due to the issuance of $500 million in 7 1/8% Senior Notes (March 2007) and $500 million in 8 1/8% Senior Notes (September 2007), as well as a $180 million credit facility provided to Premier.

Guidance, Outlook, Risks, and Unusual Items

Management Commentary & Outlook:

• Manufacturing: Idaho Timber and Conwed Plastics continue to face headwinds from weak housing starts and reduced demand. Management is focusing on cost control and product diversification.
• Medical Product Development: Sangart remains a development-stage company with no product sales. Significant R&D expenses are expected to continue as Phase III clinical trials for Hemospan proceed, with regulatory approval not expected until 2008 or later.
• Investments: The company has made significant capital commitments to associated companies, including $600 million to Jefferies High Yield Holdings (JHYH) and $200 million to Pershing Square. The timing of remaining contributions to JHYH is at the discretion of Jefferies.

• Legal Proceedings: A settlement of approximately $13.8 million has been reached regarding the MK Resources acquisition litigation. Payment is expected in Q4 2007. An additional $7.5 million expense was accrued in Q1 2007.
• Premier Bankruptcy: Premier emerged from bankruptcy in August 2007. While the reorganization plan was funded, noteholders have claimed liquidated damages. The company has funded a $13.7 million escrow for these claims but has not accrued a loss as the outcome is not deemed probable.
• Tax Valuation Allowance: The company maintains a deferred tax valuation allowance of approximately $860 million. Realization of this asset depends on future taxable income projections, which are inherently uncertain.
• Forward-Looking Statements: The filing includes standard disclaimers regarding risks such as economic downturns, housing market changes, raw material volatility, and regulatory changes.

• Discontinued Operations: The 2006 results were heavily influenced by gains on the disposal of discontinued operations (Symphony and ATX). In 2007, gains from discontinued operations were minimal ($2.0 million for the nine months).
• Acquisition Accounting: The acquisition of Sangart resulted in the immediate expensing of $4.0 million of acquired research and development costs under GAAP purchase method rules.

Investor Verification Checklist

• Deferred Tax Asset Realization: Verify the company's projections for future taxable income to support the $860 million deferred tax valuation allowance.
• Premier Escrow Liability: Monitor the court proceedings regarding the $13.7 million escrow for Premier noteholder damages to assess potential future losses.
• Sangart Clinical Trials: Track the progress and results of Sangart's Phase III clinical trials, as failure would result in continued losses with no near-term revenue.
• Debt Service Coverage: Assess the company's ability to service the increased debt load ($1 billion in new senior notes issued in 2007) given the decline in operating cash flow.
• Investment Valuations: Review the fair value of significant equity investments (e.g., Fortescue, Pershing Square, JHYH) which are subject to market volatility and equity method accounting adjustments.